期刊文献+

二尖瓣置换术联合左心房减容术、改良迷宫Ⅲ型术治疗风湿性心脏瓣膜病并慢性心房颤动

Mitral Valve Replacement Combined with Left Atrial Volume Reduction Surgery and Modified Maze Ⅲ Procedure for Rheumatic Heart Disease Associated with Chronic Atrial Fibrillation
下载PDF
导出
摘要 目的探讨二尖瓣置换术联合左心房减容术、改良迷宫Ⅲ型术治疗风湿性心脏瓣膜病并慢性心房颤动(at-rial fibrillation,AF)的临床疗效。方法将60例左心房容积指数(LAVI)≥55mL.m-2的风湿性心脏瓣膜病并慢性AF患者按不同的治疗方法分为2组:二尖瓣置换术联合左心房减容术、改良迷宫Ⅲ型术组(LAVR组),30例;二尖瓣置换术联合改良迷宫Ⅲ型术组(对照组),30例。观察2组患者围术期的体外循环(CPB)时间、主动脉阻闭时间、呼吸机辅助时间、ICU时间、住院时间、胸瓶引流量和术后并发症发生率、病死率及术前、术毕,术后1、3、6、12个月窦性心律维持率、术前和术后12个月心功能NYHA分级、左心房内径(LAD)、左心房容积指数(LAVI)、左心室射血分数(LVEF)、心胸比(C/T)、术前和术后第1、7天,6个月血浆脑利钠肽(BNP)水平等情况。结果 2组患者CPB时间、主动脉阻闭时间、呼吸机辅助时间、ICU时间、住院时间、胸瓶引流量及术后并发症发生率、病死率比较差异均无统计学意义(均P>0.05)。LAVR组患者术后1、3、6、12个月窦性心律维持率均明显高于对照组,差异均有统计学意义(均P<0.05)。LAVR组患者术后12个月心功能NA分级明显好于对照组(P<0.05)。LAVR组患者术后12个月LAD、LAVI、LVEF、C/T值与对照组比较差异均有统计学意义(均P<0.05)。LAVR组患者术后第1、7天,6个月血浆BNP水平与对照组比较差异均有统计学意义(P<0.05或P<0.01)。结论对LAVI≥55mL.m-2的风湿性心脏瓣膜病并慢性AF患者行二尖瓣置换术联合左心房减容术、改良迷宫Ⅲ型术治疗有较好的疗效,并可预防术后AF复发,长期维持窦性心率,进一步改善左心房、室主动收缩功能。 Objective To explore the curative effects of mitral valve replacement(MVR) combined with left atrial volume reduction surgery(LAVR) and modified maze Ⅲ procedure on rheumatic heart disease(RHD) associated with chronic atrial fibrillation(AF).Methods According to different treatment methods,60 RHD patients with chronic AF and left atrial volume index(LAVI) ≥55 mL·m-2 were divided into two groups:MVR combined with LAVR and modified maze Ⅲ procedure group(LAVR group,30 patients) and MVR combined with modified maze Ⅲ procedure group(control group,30 patients).Perioperative parameters,including cardiopulmonary bypass(CPB) time,aortic occlusion time,auxiliary ventilation time,ICU time,hospital stay,chest bottle drainage and incidence of postoperative complications,and mortality rate were observed in the two groups.Sinus rhythm maintenance rate was measured surgery before,surgery completed and 1,3,6 and 12 months after operation.The New York Heart Association(NYHA) functional classification,left atrial diameter(LAD),left atrial volume index(LAVI),left ventricular ejection fraction(LVEF) and cardiothoracic ratio(C/T) were determined before and 12 months after operation.Plasma brain natriuretic peptide(BNP) levels were detected before and 1 day,7 days and 6 months after operation.Results There were no significant differences in CPB time,aortic occlusion time,auxiliary ventilation time,ICU time,hospital stay,chest bottle drainage and incidence of postoperative complications,and mortality rate between LAVR group and control group(P0.05).The sinus rhythm maintenance rate,NYHA functional classification,LAD,LAVI,LVEF,C/T and BNP levels were significantly improved in LAVR group compared with control group(P0.05 or P0.01).Conclusion MVR combined with LAVR and modified maze Ⅲ procedure is curative effect in RHD patients with chronic AF and LAVI≥55 mL·m-2,and can prevent postoperative AF recurrence,maintain sinus rhythm and further improve the left atrial and ventricular contraction function.
出处 《南昌大学学报(医学版)》 CAS 2011年第9期50-55,共6页 Journal of Nanchang University:Medical Sciences
关键词 风湿性心脏瓣膜病 慢性心房颤动 二尖瓣置换术 左心房减容术 改良迷宫Ⅲ型术 窦性心律 脑利钠肽 rheumatic heart disease chronic atrial fibrillation mitral valve replacement left atrial volume reduction surgery modified maze Ⅲ procedure sinus rhythm brain natriuretic peptide
  • 相关文献

参考文献14

二级参考文献74

  • 1李莉,张宝仁,汪曾炜,朱家麟,郝家骅,梁焕炜,张新波,王华,郭素华.风湿性心脏病手术前后房颤发生率及其预后分析[J].第二军医大学学报,1997,18(S1):89-91. 被引量:21
  • 2杨青,凌世长,汤健,苏静怡,唐朝枢,赵云涛,石湘芸.心钠素对离体大鼠心脏缺钙-复钙损伤的治疗作用[J].北京医科大学学报,1994,26(2):96-98. 被引量:4
  • 3杜日映,蔡振杰,王毅.射频迷宫术治疗心房颤动[J].中国心脏起搏与心电生理杂志,1996,10(2):62-63. 被引量:15
  • 4Levin E R, Gardner D G, Samson W K, et al. Natriuretic peptides[ J ]. N Engl J Med, 1998,339 ( 5 ) :321-328.
  • 5Bettencourt P, Ferreira A, Dlas P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure [ J ]. Cardiology, 2000,93 ( 1 - 2 ) : 19 - 25.
  • 6Nishigaki K, Tomita M, Kagawa K, et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy[ J ]. Am Coll Cardiol, 1996, 28(5) :123-142.
  • 7Ellinor P T, Low A F, Patton K K, et al. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation [ J ]. J Am Coll Cardiol,2005,45 ( 1 ) :82-86.
  • 8Pfister R, Schneider C A. Natriuretic peptides BNP and NT-pro- BNP :established laboratory markers in clinical practice or just perspectives [ J ]. Clin Chim Aeta, 2004,349 ( 1 - 2 ) : 25- 38.
  • 9Song M H, Kobayashi Y, Michi H. Clinical implication of atrial and brain natriuretic peptide in coronary artery bypass grafting [ J ]. Asian Cardiovasc Thorac Ann,2004,12 ( 1 ) :41-46.
  • 10Melo L G, Pang S C, Ackermann U. Atrial natriuretic peptide: regulator of chronic arterial blood pressure [ J ]. News Physiol Sci ,2000,15 : 143-149.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部